Linezolid Teva Pharma (Linezolid)

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

• Gram‑positive bacterial infections: effective against resistant strains such as MRSA and VRE.
• Skin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections.
• Community‑acquired pneumonia: improves clinical outcomes in adult patients.
• Hospital‑acquired pneumonia: provides therapy for severe nosocomial pneumonia.

• Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations, targeting a broad range of Gram‑positive pathogens.

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools that may be self‑limiting.
• Headache: transient cranial discomfort.
• Metallic taste: altered taste perception.
• Vomiting: occasional emesis.
• Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count.
• Peripheral neuropathy: numbness or tingling in extremities.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: metabolic disturbance with elevated lactate.
• Optic neuropathy: visual disturbances or loss.
• Severe hypotension: marked drop in blood pressure.

Before prescribing Linezolid, clinicians should consider several safety factors.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: assess liver enzymes regularly.
• Concomitant serotonergic drugs: avoid due to serotonin syndrome risk.
• MAO inhibitors: contraindicated because of hypertensive crisis potential.
• Myelosuppression: perform periodic complete blood counts.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• MAO inhibitors: may cause hypertensive crisis.
• Serotonergic agents (SSRIs, SNRIs, tramadol): risk of serotonin syndrome.
• Rifampin: reduces linezolid plasma concentrations.
• Anticoagulants (warfarin): may increase bleeding risk.
• Anticonvulsants (carbamazepine, phenytoin): may lower linezolid levels.

Moderate Interactions (Monitor Closely)

• NSAIDs: potential additive effect on bleeding.
• Ethanol: possible disulfiram‑like reaction.
• Digoxin: monitor serum levels for possible increase.
• Beta‑blockers: may enhance hypotensive effect.
• Proton pump inhibitors: observe for altered absorption.